*ST Haili (603718)
Overview
Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and rel
Employees340
Market Cap$2.2B
Revenue$173.5M
Listed OnShanghai Stock Exchange
Ticker603718
CEOMr. Benyi Han
HeadquartersShanghai